See also this year's filing and all EDGAR filings for this company.
PDF Report 0001442836_2024_Mersana_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001442836, Mersana Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 214,057,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 12,003,000 |
| 4 | LiabilitiesCurrent | 63,637,000 |
| 5 | LiabilitiesNoncurrent | 125,519,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 63,385,473 |
| 9 | ResearchAndDevelopmentExpense | 135,068,550 |
| 10 | remainder_Expenses | 8,713,000 |
| 11 | remainder_Revenues | 34,111,003 |
| 12 | remainder_NetIncome | 49,055,681 |
| 13 | remainder_ComprehensiveNetIncome | -39,431 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 226,060,000 |
| 1 | Liabilities | 189,156,000 |
| 2 | Expenses | 207,167,023 |
| 3 | Revenues | 34,111,003 |
| 4 | StockholdersEquity | 36,904,000 |
| 5 | NetIncome | -124,000,339 |
| 6 | ComprehensiveNetIncome | -124,020,054 |
| 7 | BaseVar | 352,794,569 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.210 |
| 9 | EconomicCapitalRatio | 1.41 |
Edgar->Model Mapping
Feature Distribution
Change over Time
